MedPacto has confirmed the clinical efficacy of its Vactosertib response gene signature (VRGS), a biomarker under development, which can find colon cancer patients who will respond to combined therapy. The company’s VRGS can tell who will show a therapeutic response when administered Vactosertib com
The Russian Direct Investment Fund (RDIF) said that GL Rapha, a Korean biotech firm, will manufacture 150 million doses of Sputnik V, a Russian-developed Covid-19 vaccine, annually.Under the accord, GL Rapha, including its subsidiary Hankook Korus Pharma, will begin manufacturing the vaccines next m
Korea will become an integral part of fighting off future pandemics with the nation's accumulated experience from fighting Covid-19, according to Trevor Mundel, president of Global Health at the Bill & Melinda Gates Foundation and chair of the RIGHT (Research Investment for Global Health Technology)
Lundbeck Korea and its labor union reached a tentative deal on a new labor contract Wednesday night and averted a collective action.Lundbeck Korea and the union made a provisional agreement on all 141 issues, according to the union. The tentative deal includes guaranteeing the union's basic activiti
Daewoong Pharmaceutical said Wednesday that it has confirmed the efficacy of its combination drug, “Olostar,” which treats hypertension and dyslipidemia, and published its research in the "American Journal of Therapeutics." The company conducted clinical trials on 112 patients over 18 suffering from
Pharmaceutical industry officials have become increasingly worried about a confirmed Covid-19 case in a drug sales representative at a local company.According to sources on Wednesday, one employee of Handok was diagnosed with Covid-19 infection, and two more Handok workers got the viral infection.Th
The share prices of Covid-19-related biopharmaceutical companies widened losses on Wednesday morning, upon news that Pfizer and BioNTech’s vaccine has shown an efficacy rate of over 90 percent in a phase 3 trial.As of 12:30 p.m., Genexine, which had been conducting trials for GX-19, registered the l
Korean drugmakers made technology export of 9.1 trillion won ($8.18 billion) in the first 10 months of this year, hitting a record high amid the Covid-19 pandemic, an industry group said recently. According to a report by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), dom
Hanmi Pharmaceutical said that the Ministry of Food and Drug Safety has approved its Amosartan XQ, the world's first four combination therapy.The drug, which treats hypertension and hyperlipidemia, combines two hypertension treatments -- amlodipine and losartan – with two dyslipidemia treatments of
The outpatient prescription amount of choline alfoscerate drugs has continued to grow as the result of an increase in long-term prescription despite the controversy over its effectiveness, according to market sources.According to UBIST, a drug market surveyor, the prescription for choline alfoscerat
Deargen Inc., an AI-based drug developer, said that it signed a contract with SK Chemical last week to conduct joint researches on “drug repositioning” and “de novo drug design.” Under the agreement, Deargen will carry out drug repositioning – inducing effective substance from existing medicines or
A prolonged outbreak of the Covid-19 is forcing multinational pharmaceutical companies to use early retirement program (ERP) to reduce the number of drug sales representatives.Sanofi, Lilly Korea, and Roche Korea have recently announced that they would operate ERP on all or part of salespersons.Sano
Two pharmaceutical companies have challenged to achieve a functional cure of chronic hepatitis B, which requires a lifetime of therapy, but only one of them made meaningful progress. A functional cure refers to a situation where a virus remains in the body but is controlled by the immune system with
ABL Bio said Friday that it has ceased the joint of development of ABL901, a Covid-19 antibody treatment, with HiFiBiO Therapeutics as they could not agree on the commercial viability of the drug.The two companies agreed to an antibody treatment using cured Covid-19 patients' blood in September and
Celltrion presented the Phase 1 and 3 clinical trial results of CT-P17, a biosimilar of autoimmune rheumatoid treatment, Humira (ingredient: adalimumab), at the online conference of American College of Rheumatology (ACR) on Friday and Saturday. ACR selected Celltrion as the poster presenter to demon
SK Biopharmaceuticals said its original epilepsy drug, cenobamate, branded as XCOPRI in the U.S., has demonstrated potential by marking a series of excellent records this year.Cenobamate has been selected as one of the 100 best national research and development products by the Ministry of Science an
Several local branches of multinational pharmaceutical companies have appointed new CEOs to boost their competitiveness and enhance strategic sectors in the second half of this year.Sanofi Pasteur, Galderma, Ono Pharma, MSD, Organon, and GSK are such companies. Galderma, Ono Pharma, and Organon have
Preventive treatment is most important for severe hemophilia patients, an expert said, noting that administrating recombinant factors only when patients bleed is no longer be considered a long-term treatment option.Professor Choi Eun-jin of the Department of Pediatrics and Adolescents at the Daegu C
Domestic pharmaceutical companies said they were preparing to roll out latecomer drugs to target Tanelia (ingredient: teneligliptin hydrobromide hydrate), the original DPP-4 (dipeptidyl peptidase 4) inhibiting diabetes treatment.On Thursday, the Ministry of Food and Drug Safety approved eight medici
Last month, a parliamentary audit on the Ministry of Food and Drug Safety revealed that some people sold and purchased prescription medicines illegally on a secondhand marketplace Danggeun Market using mobile phones. Three weeks later, however, illicit practices are still ongoing.People were selling